BioSpace News Archive

Although medical marijuana is becoming more mainstream, limited research on its effective use combined with a rapidly changing market present challenges for case managers who must incorporate these new therapeutic options in an ethically sound and evidence-based manner.

The latter is an involved surgery where blood flow to the body, with the exception of the brain, is completely stopped for up to 45 minutes while the body is rapidly cooled to lower metabolism and oxygen usage.

Kewaunee Scientific Corporation announced its Board of Directors declared a quarterly cash dividend of nineteen cents per outstanding share, payable on September 24, 2019 to stockholders of record at the close of business on September 10, 2019.

DarwinHealth today announced a multi-year scientific research collaboration with Celgene Corporation (“Celgene”) to use quantitative systems biology-based algorithms, technologies that also underpin NY State CLIA-approved diagnostic tests in oncology, and novel, validated approaches focused on tumor checkpoint-targeted therapy to support Celgene’s clinical development efforts with respect to certain specified compounds.

Hyundai Hope On Wheels®, a 501 nonprofit organization, hosts the “Hands on Hope: 50 Hours for $50,000" competition in honor of National Childhood Cancer Awareness month.

Cancer Insight is Instrumental in Securing CPRIT Funding for Companies Developing Novel Cancer Treatments

The scope of the Genomics SC is “Standardization of computable data, information, and knowledge, including their representation and metadata, for the application of omics, including but not limited to genomics, transcriptomics and proteomics, to support human health and clinical research.”

Mr. Karalis, who currently serves as BioMatrix Chief Operating Officer, assumed the role on July 1, 2019. He will also serve on the company’s Board of Directors.

The new study was published in Carcinogenesis in May 2019.

To help families and caregivers understand the evolving drug development process, in particular with gene therapies, CureDuchenne, the global leader focused on funding and finding a cure for Duchenne, announced today it will host a free webinar for the Duchenne community.